Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
|
Investment Grade:
|
|
Comments(0)
|
(0)
|
(0)
|
Ranking History
Headlines
- Earnings Preview For Nov 3 - 7 - Earnings Preview
Oct 31, 2008 10:03 PM
- Institutional Money Flocking in Biotech
Aug 15, 2008 01:23 PM
- Few Thoughts and a Look at the Earnings in the Coming Week
Jul 28, 2008 01:20 AM
- Alseres Pharmaceuticals to Host 2008 First Quarter Conference Call and PDL BioPharma shares hit 5-year low on wider 1Q loss
May 12, 2008 08:59 AM
- More Bad News From Financials
May 09, 2008 10:04 AM
- PDL BioPharma Reports First Quarter 2008 Financial Results and Halozyme Therapeutics Reports 2008 First Quarter Financial Results
May 09, 2008 09:29 AM
- Biotechs Coming Alive:
Apr 15, 2008 02:16 AM
- Media Digest for 4/14
Apr 14, 2008 10:33 AM
- Is Bad News Already Priced In?
Apr 11, 2008 10:16 AM
- Biotechs Coming Alive: SPX, Nasdaq, MLNM, AMGN, OSIP, IMCL, PDLI, DNA, XBI, IBB, MTL
Apr 10, 2008 09:16 PM
- PDL BioPharma Announces Record Date for Spin-Off of Biotechnology Operations
Nov 19, 2008 09:06 AM
- PDL BioPharma Reports Third Quarter 2008 Financial Results and Updates 2008 Guidance for Royalty Revenues
Nov 06, 2008 04:02 PM
- PDL BioPharma Appoints John P. McLaughlin to Become President and CEO Upon Completion of Spin-Off of Biotechnology Assets
Nov 06, 2008 09:00 AM
- PDL BioPharma Announces November 6 Webcast of Third Quarter 2008 Financial Results Conference Call
Oct 24, 2008 04:00 PM
- PDL BioPharma Elects Paul Sandman and John McLaughlin to Its Board of Directors
Oct 10, 2008 04:01 PM
- PDL BioPharma Names Faheem Hasnain President and Chief Executive Officer
Sep 25, 2008 08:01 AM
- PDL BioPharma Announces Participation at the UBS Global Life Sciences Conference and Webcast Presentation on September 25
Sep 23, 2008 07:15 PM
- BellwetherReport.Com Analyst Opinions on OTEX, PDLI, DISH and ALTR
Aug 20, 2008 12:54 PM
- PDL BioPharma Announces Investor Conference Call Today
Aug 19, 2008 04:05 PM
- Bristol-Myers Squibb and PDL BioPharma Enter Global Alliance to Develop Novel Treatment for Multiple Myeloma
Aug 19, 2008 04:02 PM
- Form 4 SANDMAN PAUL W For: Oct 08 (10K)
Oct 10, 2008 05:32 PM
- Form 3 SANDMAN PAUL W For: Oct 08 (10K)
Oct 10, 2008 05:32 PM
- Form 3 MCLAUGHLIN JOHN PETER For: Oct 08 (10K)
Oct 10, 2008 05:30 PM
- Form 4 MCLAUGHLIN JOHN PETER For: Oct 08 (10K)
Oct 10, 2008 05:29 PM
- Form 3 PDL BIOPHARMA, INC. For: Oct 01 Filed by: Hasnain Faheem (10K)
Oct 03, 2008 12:24 PM
- Form 4 PDL BIOPHARMA, INC. For: Oct 01 Filed by: Hasnain Faheem (10K)
Oct 03, 2008 12:23 PM
- Form 4 Sarena Francis Willard For: Sep 15 (10K)
Sep 17, 2008 01:06 PM
- Form 4 CROSS HERB For: Sep 15 (10K)
Sep 17, 2008 01:04 PM
- Form 3 PDL BIOPHARMA, INC. For: Aug 13 Filed by: Hora Maninder (10K)
Aug 20, 2008 05:16 PM
- Form 4 MURRAY RICHARD /CA/ For: Jul 21 (10K)
Jul 22, 2008 06:08 PM
Analyst Ratings
|
|
Share Performance
|
Period
|
PDLI
|
Compare to S&P
|
| YTD |
-47.55 %
|
-8.73 %
|
| 4 Weeks |
1.43 %
|
12.78 %
|
| 12 Weeks |
-25.83 %
|
17.86 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: -77.78 %
|
|
EPS Growth in Last Year: -50.00 %
|
|
Sales Growth in Last Quarter: -30.88 %
|
|
Sales Growth in Last Quarter: -29.73 %
|
|
|
